From day 20 on, a clear trend toward lower values in the combined treatment group (MTX+CF101) was observed, as compared with the control group and each of the other treatment groups (Figure 1a ).
← all excerpts
Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A3 adenosine receptor expression.
1
—
—